Literature DB >> 29732586

Lung Ultrasonography for Assessing Lung Aeration in Acute Respiratory Distress Syndrome: A Narrative Review.

Gabriela Bello1,2, Pablo Blanco3.   

Abstract

Acute respiratory distress syndrome (ARDS) constitutes a high burden for intensive care units. Although several methods are proposed to monitor aeration in ARDS, availability, costs, simplicity, and hazards (eg, ionizing radiation) limit the use of many of them at patients' bedsides. Given the widespread use of lung ultrasonography (US) in intensive care units, research is growing regarding its use to monitor aeration in patients with ARDS. We reviewed the actual role of lung US in ARDS and its potential impact in practice. Lung US can be readily used for assessing aeration, although, as a main limitation, a normal lung cannot be distinguished from hyperinflation. Additionally, an improvement in aeration by lung US does not always correlate with an increase in oxygenation. Lung US can be considered the main imaging method for monitoring aeration in ARDS, but in view of its limitations, it should not be used in isolation. Further studies are needed to validate lung US in large ARDS populations.
© 2018 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  acute respiratory distress syndrome; lung; mechanical ventilation; point of care; ultrasonography

Mesh:

Year:  2018        PMID: 29732586     DOI: 10.1002/jum.14671

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  9 in total

Review 1.  Biomarkers in pediatric acute respiratory distress syndrome.

Authors:  Erin F Carlton; Heidi R Flori
Journal:  Ann Transl Med       Date:  2019-10

Review 2.  Extracardiac Complications in Intensive Care Units after Surgical Repair for Congenital Heart Disease: Imaging Review with a Focus on Ultrasound and Radiography.

Authors:  Takahiro Hosokawa; Saki Shibuki; Yutaka Tanami; Yumiko Sato; Yoshihiro Ko; Koji Nomura; Eiji Oguma
Journal:  J Pediatr Intensive Care       Date:  2020-09-09

3.  Early assessment of lung aeration using an ultrasound score as a biomarker of developing bronchopulmonary dysplasia: a prospective observational study.

Authors:  Ignacio Oulego-Erroz; Paula Alonso-Quintela; Sandra Terroba-Seara; Aquilina Jiménez-González; Silvia Rodríguez-Blanco
Journal:  J Perinatol       Date:  2020-07-14       Impact factor: 2.521

4.  Combined lung and cardiac ultrasound in COVID-related acute respiratory distress syndrome.

Authors:  Chiara Lazzeri; Manuela Bonizzoli; Stefano Batacchi; Filippo Socci; Marco Matucci-Cerinic; Adriano Peris
Journal:  Intern Emerg Med       Date:  2021-03-11       Impact factor: 3.397

5.  Lung Ultrasonography in the Monitoring of Intraoperative Recruitment Maneuvers.

Authors:  Jolanta Cylwik; Natalia Buda
Journal:  Diagnostics (Basel)       Date:  2021-02-10

6.  Correlation Analysis between Mechanical Power and Lung Ultrasound Score and Their Evaluation of Severity and Prognosis in ARDS Patients.

Authors:  Yongpeng Xie; Suxia Liu; Zhifang Mou; Yanli Wang; Xiaomin Li
Journal:  Biomed Res Int       Date:  2021-09-01       Impact factor: 3.411

7.  Prophetic values of lung ultrasound score on post-extubation distress in patients with acute respiratory distress syndrome.

Authors:  Ran Wang; Benquan Qi; Xiaohua Zhang; Liang Meng; Xiaofei Wu
Journal:  Eur J Med Res       Date:  2022-02-22       Impact factor: 2.175

8.  Randomized field trial comparing the efficacy of florfenicol and oxytetracycline in a natural outbreak of calf pneumonia using lung reaeration as a cure criterion.

Authors:  Stan Jourquin; Jade Bokma; Lieze De Cremer; Katharina van Leenen; Nick Vereecke; Bart Pardon
Journal:  J Vet Intern Med       Date:  2022-01-07       Impact factor: 3.333

9.  Are pocket sized ultrasound devices sufficient in the evaluation of lung ultrasound patterns and aeration scoring in pulmonary ICU patients?

Authors:  Tuba Güney; Gül Gürsel; Uğur Özdemir; Ömer Tekin; Meltem Çimen; Ayşen Mamadova; Nur Karaaslan
Journal:  J Clin Monit Comput       Date:  2020-11-10       Impact factor: 1.977

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.